Monday, May 13, 2024
Monday, May 13, 2024
HomeTagsTherapeutics

Tag: therapeutics

-Advertisement-

Gallant Therapeutics Raises Over $15 Million in Series A Funding to Advance Pipeline of “Off-the-Shelf” Stem Cell Therapies for Pets

Leading Investors BOLD Capital, Digitalis Ventures, and Hill Creek Partners drive monetary milestone Financing to expedite conditional FDA approval of lead candidate and derisk...

[Latest] Pet Cancer Therapeutics Market Size Will Attain USD 15 Billion by 2030 Rising at 7% CAGR

Rise within the unmet medical wants and rising potential of pet most cancers treating medicine will open new development alternatives for the worldwide pet...

TransCode Therapeutics To Present Phase 0 Data at 2023 San Antonio Breast Cancer Symposium

BOSTON, Dec. 05, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology firm dedicated to extra successfully treating most cancers utilizing...
- Advertisement -

International Canine Flu Therapeutics Industry suggests it would attain US$ 3.06 Billion by 2033, buoyed by a 4.1% CAGR | FMI

Canine Flu Therapeutics Industry The global canine flu therapeutics industry is anticipated to...

TransCode Therapeutics Reports Third Quarter 2023 Results; Provides Business Update

BOSTON, Nov. 14, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology firm dedicated to extra successfully treating most cancers utilizing...

TransCode Therapeutics Announces Preliminary Clinical Results in First Patient in Phase 0 Clinical Examine with Lead Therapeutic Candidate, TTX-MC138

Evidence of Drug Accumulation in Metastatic LesionsBOSTON, Oct. 24, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology firm dedicated to...
- Advertisement -

TransCode Therapeutics Announces Positive Pre-Clinical Glioblastoma Results with Lead Therapeutic Candidate, TTX-MC138

Further Supports TTX-MC138 Application in Brain CancerBOSTON, Sept. 25, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology firm dedicated to...
-Advertisement-

Must read

-Advertisement-